Ophthalmic Sutures Market Size, Share & Trends Analysis Report By Type (Synthetic, Natural), By Absorption Capacity, By Application (Corneal Transplant Surgery, Cataract Surgery), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment

Ophthalmic Sutures Market Size, Share & Trends Analysis Report By Type (Synthetic, Natural), By Absorption Capacity, By Application (Corneal Transplant Surgery, Cataract Surgery), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecast, 2025 - 2030


Ambulatory Surgery Centers IT Services Market Growth & Trends

The global ambulatory surgery centers IT services market size is projected to reach USD 426.9 billion by 2030 and is anticipated to expand at a CAGR of 10.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing need for integrated services that help in improving patient care in Ambulatory Surgical Centers (ASCs) is positively impacting the growth. Furthermore, the growing number of outpatient surgical procedures coupled with the rising need to curb the increasing healthcare expenditure in these settings is further bolstering revenue growth over the forecast period.

Based on the service type, the EHR segment dominated the market with a revenue share of 27.8% in 2019. Factors contributing to the increase in demand include increasing adoption of healthcare IT solutions by ASCs for faster and better performance of healthcare processes, which helps improve the quality of healthcare delivery. On the other hand, the clinical documentation segment is expected to expand at the fastest CAGR over the forecast period.

In 2019, the service segment accounted for the highest revenue share, attributed to the shift of healthcare IT solutions toward cloud computing coupled with increasing utilization of IT solutions by ASCs to control growing administrative overheads and improve the efficiency of ambulatory services.

Based on delivery mode, the cloud-based segment dominated the market with a revenue share of 84.4% in 2019. The rapidly improving healthcare technology, changing reimbursement policies, and increasing number of procedures in ASCs have increased the use of cloud-based IT tools. These tools help to optimize clinical and non-clinical processes, which in turn is driving the demand for cloud-based solutions in the outpatient surgery space.

North America dominated the market for ambulatory surgical centers IT services with a revenue share of 57.6% in 2019 owing to the presence of the largest number of ASCs in the U.S. coupled with the rising number of surgical procedures performed in ASC settings and the presence of major market players in the region. On the other hand, the Asia Pacific region is projected to expand at a lucrative CAGR over the forecast period. It is attributable to increasing healthcare expenditure and growing government initiatives to adopt healthcare IT services in this region.

Ambulatory Surgery Centers IT Services Market Report Highlights
  • Revenue cycle management led the product segment, dominating the market with the largest revenue share of 49.6% in 2024, encompassing processes to manage claims, payments, and revenue generation data.
  • Software dominated the market and accounted for the largest revenue share of 61.2% in 2024 due to an increase in all-inclusive management solutions that enhance several clinical and administrative procedures in ASCs.
  • Web/Cloud Base contributed the largest revenue share of 78.3% in 2024 due to wide cloud computing offerings, including scalability, cost-effectiveness, and accessibility.
  • North American ambulatory surgery centers IT services market dominated the global market and accounted for the largest revenue share of 54.3% in 2024 due to the advanced healthcare sector and significant investment in healthcare technology.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Absorption Capacity
1.2.3. Application
1.2.4. End Use
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Absorption capacity outlook
2.2.3. Application outlook
2.2.4. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Ophthalmic Sutures Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising aging population
3.2.1.2. Increasing incidence of visual impairment
3.2.1.3. Increasing awareness about an eye disorder
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of treatment
3.2.2.2. Lack of skilled professionals
3.3. Ophthalmic Sutures Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Ophthalmic Sutures Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Ophthalmic Sutures Market: Type Movement Analysis
4.3. Ophthalmic Sutures Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Natural
4.5.1. Natural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Synthetic
4.6.1. Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Ophthalmic Sutures Market: Absorption Capacity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Ophthalmic Sutures Market: Absorption Capacity Movement Analysis
5.3. Ophthalmic Sutures Market by Absorption Capacity Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Absorbable Sutures
5.5.1. Absorbable Sutures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Non-absorbable Sutures
5.6.1. Non-absorbable Sutures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Ophthalmic Sutures Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Ophthalmic Sutures Market: Application Movement Analysis
6.3. Ophthalmic Sutures Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Corneal Transplantation Surgery
6.5.1. Corneal Transplantation Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cataract Surgery
6.6.1. Cataract Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Vitrectomy Surgery
6.7.1. Vitrectomy Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Iridectomy Surgery
6.8.1. Iridectomy Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Oculoplastic Surgery
6.9.1. Oculoplastic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Ophthalmic Sutures Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Ophthalmic Sutures Market: End Use Movement Analysis
7.3. Ophthalmic Sutures Market by End Use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospitals
7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Ambulatory Surgical Centers
7.6.1. Ambulatory Surgical Centers Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Ophthalmic Sutures Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/ reimbursement structure
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement structure
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ reimbursement structure
8.7.6.3. Competitive scenario
8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. Middle East & Africa
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework/ reimbursement structure
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ reimbursement structure
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ reimbursement structure
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ reimbursement structure
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2024
9.3.4. Accutome Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Type benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Asset Medical Sarl
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Type benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Alcon Inc.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Type benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Aurolab
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Type benchmarking
9.3.7.4. Strategic initiatives
9.3.8. B Braun Melsungen AG
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Type benchmarking
9.3.8.4. Strategic initiatives
9.3.9. DemeTech Corporation
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Type benchmarking
9.3.9.4. Strategic initiatives
9.3.10. FCI Ophthalmic Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Type benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Medtronic Plc
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Type benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Rumex International Co.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Type benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Surgical Specialties Corp
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Type benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Teleflex Incorporated
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Type benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Unilever.
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Type benchmarking
9.3.15.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings